Alomari Mohammad, Knewitz Daniel, Castillo Larios Rocio, St Julien Jamii, Thomas Mathew, Elli Enrique F, Bowers Steven P
Department of Surgery, Mayo Clinic, Jacksonville, Florida, USA.
HCA Florida Surgical Specialists, Department of Surgery, Trinity, Florida, USA.
J Laparoendosc Adv Surg Tech A. 2025 Jul;35(7):564-569. doi: 10.1089/lap.2025.0079. Epub 2025 May 19.
Submucosal tumors (SMT) of the esophagus and gastroesophageal junction (GEJ) are rare entities, which often present a significant challenge to surgeons. Prior studies have reported only single-modality approaches. We report our experience with SMTs using multiple surgical techniques with the intent of margin-negative resection and organ preservation. Between 2001 and 2022, a total of 55 patients underwent surgical resection for SMT of the esophagus or GEJ at our institution. We reviewed the electronic medical records to obtain demographic information and details of the operation. We also report peri- and early (<30 days) postoperative outcomes. Median age at operation was 62 years (22-93), and 54.5% were male. Endoscopic ultrasound was used in 45 (81.8%) patients preoperatively to classify tumors as possibly amenable for enucleation versus requiring mucosal resection. Forty-eight (87.3%) patients underwent minimally invasive procedures. Enucleation was performed in 23 (41.8%) patients, whereas 32 (58.2%) required full-thickness resection (wedge: 18; segmental: 11) or tumor resection with mucosectomy. One patient experienced Clavien-Dindo grade III or greater complications. There were no reoperations or postoperative mortality. Pathology revealed gastrointestinal stromal tumor in 25 (45.5%) patients, leiomyoma in 22 (40%), and other histology in 8 (14.5%). Negative surgical margins were achieved in 100% of the cases. Involvement of the cardia was associated with the need for full-thickness or tumor resection with mucosectomy (68.4% versus 31.5%, = .0214). Surveillance was conducted in 20 (36.4%) patients with a median follow-up of 656 days (210-3091). One patient had progressive multifocal disease, and another went on to develop metastatic disease. Minimally invasive approaches are appropriate in most esophageal and GEJ SMTs and are associated with low complication rates and disease recurrence. Involvement of the gastric cardia increases the likelihood of requiring full-thickness resection or tumor resection with mucosectomy rather than enucleation.
食管及胃食管交界区(GEJ)的黏膜下肿瘤(SMT)较为罕见,常常给外科医生带来重大挑战。既往研究仅报道了单一治疗方法。我们报告了采用多种手术技术治疗SMT的经验,旨在实现切缘阴性切除并保留器官。2001年至2022年期间,共有55例患者在我院接受了食管或GEJ的SMT手术切除。我们查阅了电子病历以获取人口统计学信息和手术细节。我们还报告了围手术期及术后早期(<30天)的结果。手术时的中位年龄为62岁(22 - 93岁),男性占54.5%。45例(81.8%)患者术前使用了内镜超声,以将肿瘤分类为可能适合摘除还是需要黏膜切除。48例(87.3%)患者接受了微创手术。23例(41.8%)患者进行了摘除术,而32例(58.2%)患者需要全层切除(楔形:18例;节段性:11例)或肿瘤切除联合黏膜切除术。1例患者出现Clavien-DindoⅢ级或更高级别的并发症。无再次手术或术后死亡病例。病理检查显示,25例(45.5%)患者为胃肠道间质瘤,22例(40%)为平滑肌瘤,8例(14.5%)为其他组织学类型。所有病例均实现了阴性手术切缘。贲门受累与需要全层切除或肿瘤切除联合黏膜切除术相关(68.4%对31.5%,P = 0.0214)。20例(36.4%)患者接受了随访,中位随访时间为656天(210 - 3091天)。1例患者出现进行性多灶性疾病,另1例患者继而发生转移。大多数食管和GEJ的SMT采用微创方法是合适且可行微创方法是合适的,并且并发症发生率和疾病复发率较低。胃贲门受累增加了需要全层切除或肿瘤切除联合黏膜切除术而非摘除术的可能性。